Research Identifies Risk of Ross River Virus Global Epidemic

Article

Australia's Ross River Virus (RRV) could be the next mosquito-borne global epidemic according to a new research study led by the University of Adelaide and the Australian National University. The virus has been thought to be restricted largely to Australia and Papua New Guinea where it is harbored by marsupial animals, specifically kangaroos and wallabies, and spread by mosquitoes.

These are Ross River Virus-carrying mosquitoes. Courtesy of  Dr. Emily Flies
 
Australia's Ross River Virus (RRV) could be the next mosquito-borne global epidemic according to a new research study led by the University of Adelaide and the Australian National University. The virus has been thought to be restricted largely to Australia and Papua New Guinea where it is harbored by marsupial animals, specifically kangaroos and wallabies, and spread by mosquitoes.

Published online ahead of print in the International Journal of Infectious Diseases, the research shows that the virus may have been circulating silently in the South Pacific ever since a large epidemic of more than 500,000 cases in 1979-80, thought to have been started by an infected Australian tourist who travelled to Fiji.

"Ross River Virus is found naturally in Australia, where it was circulating in kangaroos and wallabies long before the arrival of the first Australians over 40,000 years ago," says one of the project leaders Phil Weinstein, a professorial research fellow with the University of Adelaide's School of Biological Sciences. "When humans arrived, first Aboriginal Australians and then Europeans, they were bitten by the same mosquitoes and became infected: they had all of the sore joints, fever, rash, and fatigue that we associate with the disease today. Although RRV has never killed anyone, it can be extremely debilitating for several months, and up to years in a few unlucky individuals."

The 1979 epidemic in the Pacific Islands Countries and Territories was the first time that RRV had 'escaped' from its marsupial reservoir. But without marsupials, the epidemic burned itself out the following year - or so it was thought.

"The first clues about local transmission in the Pacific Islands came when more recent tourists from New Zealand and Canada who had been to the South Pacific, but not Australia, were diagnosed with RRV when they returned home," Professor Weinstein says.

In partnership with French collaborators in Tahiti and France, the researchers tested blood samples of American Samoans.

"We were surprised to find that of those who were born after the 1979-1980 epidemic and had lived in American Samoa their whole lives, a massive 63% had antibodies to RRV, strongly suggesting local transmission of the virus after 1980," says Dr Colleen Lau, NHMRC research fellow in ANU's College of Medicine, Biology and Environment.

"There are no marsupials in American Samoa, so the only reasonable conclusion is that the virus was able to circulate in local mammals rather than marsupials. If RRV can circulate in non-marsupials in the South Pacific, then it can find a home anywhere in the world.

"Isolation of the virus from non-marsupials will provide us with definitive evidence that RRV can become endemic globally."

Weinstein says, "With the large number of Australians now travelling, it would not be unreasonable to expect one or more tourists to carry RRV overseas to seed a new epidemic. With the right conditions, this could take off globally in exactly the same way that Zika did."

Source: University of Adelaide
 

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content